Shanghai Medical and Pharmaceutical Journal 2013 Issue 17 175 suo xian zhong yi yuan huo zhong yang tou ru 28 yi yuan

175 suo xian zhong yi yuan huo zhong yang tou ru 28 yi yuan
zhai zi zhong guo zhong yi yao bao

..............page:53-53

The difference between cytarabine and vidarabine
OU Meixian;LU Jinmiao;LI Shuijun

..............page:57-58,59

Consideration on responsibility of hospital pharmacist under the new medical reform
FANG Yu;ZHU Deqiu;WU Juan

..............page:54-56

Mechanism of renin-angiotensin-aldosterone system inhibitors
ZHU Lingti;ZHOU Jingmin

..............page:3-5

yao pin bu liang fan ying xin xi tong bao di 56 qi jing ti zuo yang fu sha xing zhu she ji de yan zhong bu liang fan ying
cfda wang zhan

..............page:61-62

Application of pericarpium trichosanthis injection in the treatment of phlegm stasis syndrome of coronary heart disease
ZHU Yuxia;CHEN Xiyang;CHEN Qiu

..............page:25-28

2013 nian 5-7 yue fda pi zhun xin yao gai kuang

..............page:59-61

Utilization of antihypertensive drugs in 119 sample hospitals of Shanghai during the period of 2010-2012
GUI Cheng;XI Yufei;HUANG Kun

..............page:43-48

Analysis and discussion of positive and negative stereotypes inconformity in ABO blood type appraisal
FAN Jin;ZHANG Jue

..............page:37-39

Anticoagulant drugs and its adverse reactions
WANG Yi;SUN Peinan;SHI Xiaojing

..............page:19-21,31

yi xue ji xu jiao yu da ti

..............page:63-63

shang hai fa zhan 3 zhong yang lao mo shi
zhai zi ren min wang

..............page:42-42

wo guo liang jia yi yuan huo ya zhou yi yuan guan li jiang
zhai zi yi xue lun tan wang

..............page:39-39

he feng zhi yao huo quan guo yao pin zhi liang cheng xin jian she shi fan qi ye shou pai
wang zuo

..............page:24-24

Analysis of rationality for the solvent selection of injectable antibiotics
TANG Xiaoyan

..............page:40-42

The impact and efifcacy of tanshinone IIA on serum homocysteine of 33 cases of patients with cerebral infarction
SUN Weiqing;XING Congcong;HUANG Liqin;WANG Fang;WANG Yingxia;WANG Yunfeng

..............page:32-33,34

Application of aldosterone antagonists in the treatment of heart failure
GAO Xiuren;HUANG Zhibin

..............page:15-18,19

Emergency and countermeasures of talents for pharmaceutical care in China
CHEN Zhidong

..............page:49-53

fda dui yi zuo an ji fen ke neng hui yin qi han jian dan yan zhong de pi fu fan ying
zhai zi ding xiang yuan

..............page:62-62

Inlfuence of calcium dibutyacyladenosine cyclophosphate on the left ventricular pump function of coronary heart disease in 75 cases of patients with chronic heart failure
LI Xiang

..............page:22-24

rong shuan he bing dan can tong iia dui 30 li ji xing que xue xing nao zu zhong zhi liao de lin chuang guan cha
wang xiao sha

..............page:29-31

Renin-angiotensin system inhibitors in the treatment of heart failure:clinical evidence review
GAO Xiufang;SHI Haiming

..............page:10-14

The clinical efifcacy of Wenshen-Jiangzhuo-Tongluo in the treatment of 60 cases of patients with early and middle chronic renal failure
QIANG Sheng;HUANG Ming;FENG Chunjian;DU Zhenfang

..............page:34-36,37

qu nian wo guo wang shang yao pin xiao shou e da 16 yi yuan
zhai zi zhong guo xin wen wang

..............page:31-31

Aliskiren, a direct renin inhibitor
WU Hongyi;ZHOU Jingmin

..............page:6-9

2013 shi jie wei sheng bao gao quan min jian kang fu gai yan jiu fa bu
zhai zi ren min ri bao

..............page:56-56

2013 shang hai zhong yi yao yu tian ran yao wu guo ji da hui
2013 shang hai zhong yi yao yu tian ran yao wu guo ji da hui zu wei hui

..............page:9-9

shang hai pu dong shou jia san jia fu you yi yuan luo cheng
zhai zi jian kang bao

..............page:28-28

di yi sheng hua da po guo qi gui mo bu jing ji guai quan

..............page:1-2